Rua Bioscience Limited (NZE: RUA)

Market Cap	4.75M
Revenue (ttm)	316.35K
Net Income (ttm)	-13.72M
Shares Out	163.72M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	111,669
Open	0.0300
Previous Close	0.0300
Day's Range	0.0300 - 0.0300
52-Week Range	0.0230 - 0.1210
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 24, 2025

About Rua Bioscience

Rua Bioscience Limited engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally. The company offers cannabinoid derived medicines. It is also involved in seed production and genetic discovery related activities. In addition, the company engages in plant breeding business, as well as involved in plant research activities. Rua Bioscience Limited was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. The company was founde...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: New Zealand
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: RUA

Financial Performance

In 2024, Rua Bioscience's revenue was 316,350, a decrease of -52.68% compared to the previous year's 668,484. Losses were -13.72 million, 130.2% more than in 2023.